Key Highlights

  • CDT Equity (NASDAQ:CDT) ended Tuesday, November 10, 2026 at USD 0.6425, off 23.52% from a calculated previous close of USD 0.84, landing among the steepest decliners in a published screener snapshot of 4,625 names.
  • A 1-for-20 reverse stock split, filed on November 2, 2026, became effective at 5:00 p.m. ET on November 5, 2026, shrinking shares outstanding from 20,357,283 to roughly 1,017,864.
  • Trading came to 348.86K shares at a relative Volume of 0.07, which is about 34.3% of shares outstanding (calculated) and roughly USD 224 thousand at the close (calculated).
  • The snapshot shows a Market Value of USD 653.98 thousand, no P/E, a Dividend Yield of 0.00% and EPS growth of +98.24%, plus an EPS print of USD -2,834,501.10 that appears to be a display artifact.

Why CDT Equity Sank on November 10 (-23.52%)

Canadian investors scanning US-listed health technology names saw CDT Equity close the regular session at USD 0.6425, lower by 23.52%. A calculated previous close of USD 0.84 for Monday, November 9, 2026 follows from simple arithmetic, a loss near USD 0.20 per share. Tuesday marked the third session on a split-adjusted basis, after November 6 and November 9. Restated on the old basis, USD 0.6425 equals about USD 0.032 per pre-split share and USD 0.84 about USD 0.042 (calculated). A relative volume of 0.07 implies an average near 4.98 million shares (calculated), though that average blends in pre-split trading, so the comparison cannot be relied on. The ticker remains CDT on the Nasdaq Capital Market.

The Rationale: A 1-for-20 Reverse Stock Split

The one identified catalyst is the reverse split. An 8-K signed on November 4, 2026 stated that a certificate of amendment went on file in Delaware on November 2, 2026, that the split became effective at 5:00 p.m. ET on November 5, 2026, and that split-adjusted trading started at the open on November 6, 2026. No fractional shares were created, and holders owed a fraction are paid cash based on the adjusted November 5 close. Stockholders had previously approved reverse splits and allowed the board to pick the ratio so the company stays within Nasdaq listing rules. The 8-K did not mention a deficiency notice, proceeds or any Warrant change, and published coverage turned up no results or other announcement dated November 9 or 10. In general terms, a split multiplies the quoted price by 20 and divides the share count by 20 without changing a holding's value, and trading afterward is often volatile. These are general mechanisms and not confirmed causes.

Valuation, Liquidity and Risks for CDT Equity

The market value of USD 653.98 thousand reconciles with about 1,017,864 shares at USD 0.6425 (calculated). The trailing EPS print and a P/E cannot be used, although EPS growth of +98.24% hints at a far smaller loss measured from an unclear base. Filing titles during 2026 include an S-1 registration statement and a 424B3 prospectus, which would suggest share sales and dilution, although their terms were not reviewed. Redeemable warrants change hands under CDTTW. Turnover of 348.86K shares equals about 34.3% of the 1,017,864 outstanding (calculated), a slim float where a few trades can move the price and spreads can run wide. At USD 0.6425 the stock is about 35.8% under USD 1.00 (calculated), a level Nasdaq treats as its minimum bid reference. Nothing here indicates the move will continue.

Where Things Stand

CDT Equity (NASDAQ:CDT) dropped 23.52% to USD 0.6425 on November 10, 2026, in its third session after a 1-for-20 reverse split that reduced shares outstanding from 20,357,283 to roughly 1,017,864. No separate catalyst surfaced. Market value is USD 653.98 thousand, and a handful of trades can shift the price.